Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rationale and Design of the OCEAN Study (Long-term mOno-antiplatelet Drug Strategy After perCutanEous coronAry interveNtion), A Multicenter, Prospective, Registered Branch of the RESCIND Study

NCT03725800 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.

NCT NCT03725800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03725800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rationale and Design of the OCEAN Study (Long-term mOno-antiplatelet Drug Strategy After perCutanEous coronAry interveNtion), A Multicenter, Prospective, Registered Branch of the RESCIND Study
Lead sponsor
Guangdong Provincial People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 15, 2018
Completion date
November 30, 2019
Enrollment
1,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet drug-related gastrointestinal injury